BVF INC/IL - KYMERA THERAPEUTICS INC ownership

KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 136 filers reported holding KYMERA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of KYMERA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$154,079,760
-25.7%
5,161,8010.0%4.32%
-24.3%
Q1 2024$207,504,400
+57.9%
5,161,8010.0%5.70%
+73.5%
Q4 2023$131,419,453
+99.5%
5,161,801
+8.9%
3.29%
+85.2%
Q3 2023$65,872,156
-39.5%
4,739,0040.0%1.78%
-41.5%
Q2 2023$108,949,702
-22.4%
4,739,0040.0%3.04%
-40.8%
Q1 2023$140,416,689
+19.9%
4,739,004
+1.0%
5.13%
+3.8%
Q4 2022$117,127,396
+14.7%
4,692,6040.0%4.94%
+17.1%
Q3 2022$102,158,000
+25.4%
4,692,604
+13.4%
4.22%
+7.2%
Q2 2022$81,492,000
-46.3%
4,138,758
+15.4%
3.94%
-35.2%
Q1 2022$151,787,000
-24.8%
3,586,658
+12.8%
6.07%
-17.2%
Q4 2021$201,940,000
+8.1%
3,180,6580.0%7.33%
+0.6%
Q3 2021$186,832,000
+46.4%
3,180,658
+20.9%
7.29%
+52.4%
Q2 2021$127,587,000
+24.8%
2,630,6580.0%4.78%
+24.8%
Q1 2021$102,227,000
-37.3%
2,630,6580.0%3.83%
-40.3%
Q4 2020$163,101,000
+91.9%
2,630,6580.0%6.42%
+38.6%
Q3 2020$84,997,0002,630,6584.63%
Other shareholders
KYMERA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Atlas Venture Life Science Advisors, LLC 5,350,422$159,710,09716.82%
Aquilo Capital Management, LLC 328,743$9,812,9799.46%
BVF INC/IL 5,161,801$154,079,7604.32%
Redmile Group, LLC 1,579,275$47,141,3592.85%
Deer Management Co. LLC 415,895$12,414,4662.55%
Artal Group S.A. 3,005,610$89,717,4592.29%
Baker Brothers Advisors 5,995,928$178,978,4512.29%
Avoro Capital Advisors LLC 3,888,888$116,083,3071.55%
Checkpoint Capital L.P. 82,000$2,447,7001.48%
Deep Track Capital, LP 1,500,000$44,775,0001.34%
View complete list of KYMERA THERAPEUTICS INC shareholders